OPKO Health, Inc. (OPK)
USD 1.5
(-3.23%)
USD 1.5
(-3.23%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 230.68 Million USD | 282.56% |
| 2022 | 60.3 Million USD | 13.35% |
| 2021 | 53.2 Million USD | -64.48% |
| 2020 | 149.78 Million USD | 19.12% |
| 2019 | 125.74 Million USD | 293.84% |
| 2018 | -64.87 Million USD | -197.57% |
| 2017 | 66.49 Million USD | 153.18% |
| 2016 | -125.03 Million USD | 13.29% |
| 2015 | -144.2 Million USD | -516.76% |
| 2014 | 34.6 Million USD | -17.51% |
| 2013 | 41.94 Million USD | 995.33% |
| 2012 | -4.68 Million USD | 92.53% |
| 2011 | -62.75 Million USD | -1786.92% |
| 2010 | -3.32 Million USD | 85.54% |
| 2009 | -22.99 Million USD | -535.04% |
| 2008 | 5.28 Million USD | 157.85% |
| 2007 | -9.13 Million USD | -6.31% |
| 2006 | -8.59 Million USD | 3.43% |
| 2005 | -8.9 Million USD | -1.91% |
| 2004 | -8.73 Million USD | 13.8% |
| 2003 | -10.13 Million USD | -69.26% |
| 2002 | -5.98 Million USD | 59.53% |
| 2001 | -14.79 Million USD | 58.07% |
| 2000 | -35.28 Million USD | -1046.3% |
| 1999 | -3.07 Million USD | 53.36% |
| 1998 | -6.6 Million USD | -288.24% |
| 1997 | -1.7 Million USD | 41.38% |
| 1996 | -2.9 Million USD | 46.3% |
| 1995 | -5.4 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 343.93 Million USD | 49.1% |
| 2024 Q2 | 228.87 Million USD | -33.46% |
| 2023 Q2 | 187.56 Million USD | 86.63% |
| 2023 Q1 | 100.5 Million USD | 66.67% |
| 2023 Q4 | 230.68 Million USD | 208.81% |
| 2023 Q3 | 74.7 Million USD | -60.17% |
| 2023 FY | 230.68 Million USD | 282.56% |
| 2022 Q2 | 71.89 Million USD | -59.43% |
| 2022 FY | 60.3 Million USD | 13.35% |
| 2022 Q3 | 111.39 Million USD | 54.93% |
| 2022 Q4 | 60.3 Million USD | -45.87% |
| 2022 Q1 | 177.22 Million USD | 233.13% |
| 2021 FY | 53.2 Million USD | -64.48% |
| 2021 Q1 | 203.91 Million USD | 36.13% |
| 2021 Q2 | 184.72 Million USD | -9.41% |
| 2021 Q3 | 95.69 Million USD | -48.19% |
| 2021 Q4 | 53.2 Million USD | -44.41% |
| 2020 Q4 | 149.78 Million USD | -38.05% |
| 2020 Q3 | 241.79 Million USD | -21.86% |
| 2020 Q2 | 309.45 Million USD | 10.06% |
| 2020 Q1 | 281.16 Million USD | 123.59% |
| 2020 FY | 149.78 Million USD | 19.12% |
| 2019 Q3 | 249.49 Million USD | 16.79% |
| 2019 FY | 125.74 Million USD | 293.84% |
| 2019 Q2 | 213.63 Million USD | 6117.8% |
| 2019 Q1 | -3.55 Million USD | 94.53% |
| 2019 Q4 | 125.74 Million USD | -49.6% |
| 2018 Q3 | 165.03 Million USD | 27.57% |
| 2018 FY | -64.87 Million USD | -197.57% |
| 2018 Q4 | -64.87 Million USD | -139.31% |
| 2018 Q2 | 129.36 Million USD | 959.99% |
| 2018 Q1 | -15.04 Million USD | -122.62% |
| 2017 Q4 | 66.49 Million USD | 31.07% |
| 2017 FY | 66.49 Million USD | 153.18% |
| 2017 Q1 | -27.72 Million USD | 77.83% |
| 2017 Q2 | 1.93 Million USD | 106.98% |
| 2017 Q3 | 50.73 Million USD | 2520.4% |
| 2016 Q1 | -25.05 Million USD | 82.63% |
| 2016 FY | -125.03 Million USD | 13.29% |
| 2016 Q4 | -125.03 Million USD | -34.23% |
| 2016 Q3 | -93.14 Million USD | -98.42% |
| 2016 Q2 | -46.94 Million USD | -87.37% |
| 2015 Q4 | -144.2 Million USD | -115.9% |
| 2015 Q2 | -95.26 Million USD | 57.8% |
| 2015 FY | -144.2 Million USD | -516.76% |
| 2015 Q1 | -225.73 Million USD | -752.4% |
| 2015 Q3 | -66.79 Million USD | 29.89% |
| 2014 Q4 | 34.6 Million USD | 195.78% |
| 2014 Q1 | 82.53 Million USD | 96.77% |
| 2014 FY | 34.6 Million USD | -17.51% |
| 2014 Q2 | -300 Thousand USD | -100.36% |
| 2014 Q3 | 11.69 Million USD | 3999.33% |
| 2013 Q2 | 89.87 Million USD | 131.67% |
| 2013 FY | 41.94 Million USD | 995.33% |
| 2013 Q4 | 41.94 Million USD | -40.85% |
| 2013 Q3 | 70.91 Million USD | -21.1% |
| 2013 Q1 | 38.79 Million USD | 928.07% |
| 2012 Q3 | -2.06 Million USD | 91.25% |
| 2012 Q4 | -4.68 Million USD | -126.77% |
| 2012 Q1 | -32.92 Million USD | 47.54% |
| 2012 FY | -4.68 Million USD | 92.53% |
| 2012 Q2 | -23.6 Million USD | 28.32% |
| 2011 Q3 | -34.68 Million USD | -43.07% |
| 2011 Q1 | -33.32 Million USD | -902.01% |
| 2011 FY | -62.75 Million USD | -1786.92% |
| 2011 Q4 | -62.75 Million USD | -80.92% |
| 2011 Q2 | -24.24 Million USD | 27.25% |
| 2010 Q1 | -16.98 Million USD | 26.14% |
| 2010 FY | -3.32 Million USD | 85.54% |
| 2010 Q4 | -3.32 Million USD | 49.71% |
| 2010 Q3 | -6.61 Million USD | -84.93% |
| 2010 Q2 | -3.57 Million USD | 78.94% |
| 2009 FY | -22.99 Million USD | -535.04% |
| 2009 Q1 | 15.16 Million USD | 186.83% |
| 2009 Q3 | -43.45 Million USD | -103.44% |
| 2009 Q4 | -22.99 Million USD | 47.08% |
| 2009 Q2 | -21.35 Million USD | -240.87% |
| 2008 Q1 | -941 Thousand USD | 89.7% |
| 2008 Q3 | -2.62 Million USD | -141.13% |
| 2008 Q4 | 5.28 Million USD | 301.68% |
| 2008 FY | 5.28 Million USD | 157.85% |
| 2008 Q2 | 6.37 Million USD | 777.15% |
| 2007 Q2 | 1.3 Million USD | 113.52% |
| 2007 Q3 | 6.28 Million USD | 381.76% |
| 2007 Q1 | -9.65 Million USD | -12.28% |
| 2007 Q4 | -9.13 Million USD | -245.35% |
| 2007 FY | -9.13 Million USD | -6.31% |
| 2006 Q2 | -8.8 Million USD | 0.52% |
| 2006 Q4 | -8.59 Million USD | -0.06% |
| 2006 FY | -8.59 Million USD | 3.43% |
| 2006 Q1 | -8.85 Million USD | 0.56% |
| 2006 Q3 | -8.59 Million USD | 2.43% |
| 2005 Q2 | -8.11 Million USD | 3.47% |
| 2005 Q4 | -8.9 Million USD | 0.59% |
| 2005 Q3 | -8.95 Million USD | -10.31% |
| 2005 FY | -8.9 Million USD | -1.91% |
| 2005 Q1 | -8.4 Million USD | 3.72% |
| 2004 Q4 | -8.73 Million USD | 3.36% |
| 2004 FY | -8.73 Million USD | 13.8% |
| 2004 Q1 | -9.4 Million USD | 7.18% |
| 2004 Q2 | -9.18 Million USD | 2.35% |
| 2004 Q3 | -9.03 Million USD | 1.59% |
| 2003 Q1 | -14.74 Million USD | -146.36% |
| 2003 Q2 | -13.33 Million USD | 9.6% |
| 2003 Q3 | -10.91 Million USD | 18.12% |
| 2003 Q4 | -10.13 Million USD | 7.18% |
| 2003 FY | -10.13 Million USD | -69.26% |
| 2002 Q2 | -11.38 Million USD | 15.63% |
| 2002 Q3 | -9.23 Million USD | 18.82% |
| 2002 Q4 | -5.98 Million USD | 35.21% |
| 2002 FY | -5.98 Million USD | 59.53% |
| 2002 Q1 | -13.48 Million USD | 8.81% |
| 2001 Q3 | -19.13 Million USD | -94.88% |
| 2001 Q4 | -14.79 Million USD | 22.7% |
| 2001 FY | -14.79 Million USD | 58.07% |
| 2001 Q1 | -32.98 Million USD | 6.51% |
| 2001 Q2 | -9.82 Million USD | 70.23% |
| 2000 FY | -35.28 Million USD | -1046.3% |
| 2000 Q4 | -35.28 Million USD | 3.26% |
| 2000 Q3 | -36.47 Million USD | 5.7% |
| 2000 Q2 | -38.67 Million USD | -136.2% |
| 2000 Q1 | -16.37 Million USD | -431.97% |
| 1999 Q4 | -3.07 Million USD | 26.71% |
| 1999 FY | -3.07 Million USD | 53.36% |
| 1999 Q2 | -4.7 Million USD | 7.84% |
| 1999 Q1 | -5.1 Million USD | 22.73% |
| 1999 Q3 | -4.2 Million USD | 10.64% |
| 1998 FY | -6.6 Million USD | -288.24% |
| 1998 Q4 | -6.6 Million USD | 15.38% |
| 1998 Q2 | -8.9 Million USD | -709.09% |
| 1998 Q3 | -7.8 Million USD | 12.36% |
| 1998 Q1 | -1.1 Million USD | 35.29% |
| 1997 Q2 | -1.9 Million USD | 29.63% |
| 1997 Q4 | -1.7 Million USD | -41.67% |
| 1997 Q3 | -1.2 Million USD | 36.84% |
| 1997 FY | -1.7 Million USD | 41.38% |
| 1997 Q1 | -2.7 Million USD | 6.9% |
| 1996 Q1 | -4.9 Million USD | 0.0% |
| 1996 Q2 | -4.3 Million USD | 12.24% |
| 1996 FY | -2.9 Million USD | 46.3% |
| 1996 Q3 | -3.7 Million USD | 13.95% |
| 1996 Q4 | -2.9 Million USD | 21.62% |
| 1995 FY | -5.4 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| bioAffinity Technologies, Inc. | -1.24 Million USD | 18659.598% |
| Aspira Women's Health Inc. | -331 Thousand USD | 69792.749% |
| Castle Biosciences, Inc. | -83.53 Million USD | 376.165% |
| Exact Sciences Corporation | 1.94 Billion USD | 88.166% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | 53.298% |
| Intelligent Bio Solutions Inc. | -5.43 Million USD | 4346.227% |
| iSpecimen Inc. | -2.14 Million USD | 10842.323% |
| Standard BioTools Inc. | 46.5 Million USD | -396.028% |
| Inotiv, Inc. | 382.14 Million USD | 39.635% |
| Psychemedics Corporation | 334 Thousand USD | -68966.766% |
| Prenetics Global Limited | -43.33 Million USD | 632.3% |
| RadNet, Inc. | 1.14 Billion USD | 79.915% |
| Star Equity Holdings, Inc. | -15.33 Million USD | 1604.095% |
| Neuronetics, Inc. | 2.79 Million USD | -8147.515% |
| OpGen, Inc. | 11.89 Million USD | -1839.836% |
| Exagen Inc. | -12.77 Million USD | 1906.162% |
| Bionano Genomics, Inc. | 34.88 Million USD | -561.324% |
| CareDx, Inc | -47.97 Million USD | 580.83% |
| Check-Cap Ltd. | -24.75 Million USD | 1031.827% |
| Twist Bioscience Corporation | -192.4 Million USD | 219.897% |
| Guardant Health, Inc. | 220.22 Million USD | -4.748% |
| Biodesix, Inc. | 34.3 Million USD | -572.408% |
| BioNexus Gene Lab Corp. | -5.79 Million USD | 4080.078% |
| Precipio, Inc. | -386 Thousand USD | 59862.435% |
| Natera, Inc. | -200.1 Million USD | 215.283% |
| Fulgent Genetics, Inc. | -82.56 Million USD | 379.392% |
| Sera Prognostics, Inc. | -2.02 Million USD | 11508.655% |
| 23andMe Holding Co. | -141.37 Million USD | 263.174% |
| Personalis, Inc. | -8.02 Million USD | 2975.63% |
| Aclaris Therapeutics, Inc. | -39.45 Million USD | 684.718% |
| Applied DNA Sciences, Inc. | -5.91 Million USD | 4000.599% |
| T2 Biosystems, Inc. | 33.8 Million USD | -582.312% |
| Neogen Corporation | 735.62 Million USD | 68.641% |
| Myriad Genetics, Inc. | 88.1 Million USD | -161.842% |
| ICON Public Limited Company | 3.56 Billion USD | 93.521% |
| NeoGenomics, Inc. | 269.19 Million USD | 14.305% |
| Star Equity Holdings, Inc. | -15.33 Million USD | 1604.095% |
| MDxHealth SA | 18.88 Million USD | -1121.514% |
| Prenetics Global Limited | -43.33 Million USD | 632.3% |
| Illumina, Inc. | 1.21 Billion USD | 80.998% |
| DarioHealth Corp. | -7.54 Million USD | 3156.214% |
| ENDRA Life Sciences Inc. | -2.43 Million USD | 9556.144% |
| Medpace Holdings, Inc. | -103.32 Million USD | 323.255% |
| Mainz Biomed B.V. | 349.85 Thousand USD | -65836.745% |
| Trinity Biotech plc | 63.73 Million USD | -261.935% |
| Sotera Health Company | 2.02 Billion USD | 88.611% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | 18659.598% |